BRD4 promotes the stemness of gastric cancer cells and reduces ALDH1 activity by attenuating the mir-216a-3p-mediated inhibition of the Wnt/β-catenin signaling pathway (134). The gene discussed is ALDH1A1; the disease is gastric cancer.